rs1554035881
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_005921.2(MAP3K1):c.3609C>T(p.Pro1203Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: not found (cov: 32) 
Consequence
 MAP3K1
NM_005921.2 synonymous
NM_005921.2 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.457  
Publications
0 publications found 
Genes affected
 MAP3K1  (HGNC:6848):  (mitogen-activated protein kinase kinase kinase 1) The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012] 
MAP3K1 Gene-Disease associations (from GenCC):
- 46,XY sex reversal 6Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- breast cancerInheritance: AD Classification: MODERATE Submitted by: G2P
- 46,XY complete gonadal dysgenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- 46,XY partial gonadal dysgenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74). 
BP6
Variant 5-56882809-C-T is Benign according to our data. Variant chr5-56882809-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 471693.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=0.457 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MAP3K1 | NM_005921.2 | c.3609C>T | p.Pro1203Pro | synonymous_variant | Exon 14 of 20 | ENST00000399503.4 | NP_005912.1 | |
| MAP3K1 | XM_047417218.1 | c.3609C>T | p.Pro1203Pro | synonymous_variant | Exon 14 of 18 | XP_047273174.1 | ||
| MAP3K1 | XM_047417219.1 | c.3198C>T | p.Pro1066Pro | synonymous_variant | Exon 15 of 21 | XP_047273175.1 | ||
| MAP3K1 | XM_047417220.1 | c.3198C>T | p.Pro1066Pro | synonymous_variant | Exon 15 of 21 | XP_047273176.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 33 
GnomAD4 exome 
Cov.: 
33
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
46,XY sex reversal 6    Benign:1 
Apr 06, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.